FDA Clears Remote Scanning Support Platform for MRI, CT and PET/CT
The multimodality system nCommand Lite reportedly facilitates real-time remote imaging guidance on scanning parameters and procedure assessments to licensed technologists for a variety of imaging modalities including CT and MRI.
The Food and Drug Administration (FDA) has granted 510(k) clearance for nCommand Lite, a multimodality platform that allows remote viewing of advanced imaging scans as well as access to real-time expert guidance for on-site technologists.
Developed by IONIC Health, nCommand Lite features real-time remote support on a vendor-agnostic platform for a variety of modalities including computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography/computed tomography (PET/CT).
The nCommand Lite, which will be distributed by GE HealthCare, may also be utilized for remote training as well as evaluation of scanning parameters and procedure assessments. GE HealthCare added that the nCommand Lite platform may provide enhance access to advanced imaging for patients and provide flexibility to facilities grappling with radiology workforce shortages.
“Our goal is to provide remote operations solutions that lead to increased access for patients, including patients who may require complex care and support from an off-site expert technologist,” said Rekha Ranganathan, senior vice president and general manager of Imaging Platforms and Digital Solutions, GE HealthCare. “Additionally, we recognize that health-care systems are not only looking to leverage the skills of one expert across multiple physical locations for knowledge sharing and training but have an imaging fleet that includes multiple vendors and modalities, so it was critical for us to expand our remote operations portfolio by adding IONIC Health’s nCommand Lite technology.”
(Editor's note: To subscribe to our e-newsletter, click here.)
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
